Insulin aspart, recombinant Subcutaneous and Xopenex HFA
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Xopenex HFA and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: levalbuterol
Brand name: Xopenex, Xopenex Concentrate, Xopenex HFA
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Xopenex Inhalation Solution Concentrate
- Insulin aspart, recombinant Subcutaneous-Xopenex Pediatric
- Insulin aspart, recombinant Subcutaneous-Xospata
- Insulin aspart, recombinant Subcutaneous-Xoten-C
- Insulin aspart, recombinant Subcutaneous-Xpect-AT
- Insulin aspart, recombinant Subcutaneous-Xpect-PE
- Xopenex HFA-Insulin degludec
- Xopenex HFA-Insulin Degludec (U-100) Prefilled Pens
- Xopenex HFA-Insulin Degludec (U-100) Vials
- Xopenex HFA-Insulin Degludec (U-200) Prefilled Pens
- Xopenex HFA-Insulin degludec and liraglutide
- Xopenex HFA-Insulin degludec and liraglutide Subcutaneous